Skip to main content
Retour
Watch Compare

ProMIS Neurosciences Inc.

Qualité des données : 83%
PMN
Nasdaq Manufacturing Chemicals
12,60 €
▲ 0,10 € (0,80%)
Cap. Boursière: 108,24 M
Prix
12,07 €
Cap. Boursière
108,24 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Earnings declined -1529,33% over the past year
Negative free cash flow of -28,12 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-1529,33%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-902,22%
En dessous de la moyenne du secteur (-53,41%)
ROIC-710,49%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,76
Interest CoverageN/A

Valorisation

PE (TTM)
-2,73
En dessous de la moyenne du secteur (-1,48)
P/B Ratio11,78
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,7 -1,5
P/B 11,8 1,6
ROE % -902,2 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

TBGVX TBGVX
0,77% weight
AVDVX AVDVX
0,00% weight
AVANX AVANX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -1529,33% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -39,72 M
ROE -902,22% ROA -256,52%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -28,12 M
ROIC -710,49% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,76
Interest Coverage N/A Asset Turnover N/A
Working Capital 9,25 M Tangible Book Value 9,19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,73 Forward P/E N/A
P/B Ratio 11,78 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25,98%
Market Cap 108,24 M Enterprise Value 92,84 M
Per Share
EPS (Diluted TTM) -22,61 Revenue / Share N/A
FCF / Share -3,14 OCF / Share -3,14
EPS CAGR (1Y) -20654,55% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 70,79%
SBC-Adj. FCF -28,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -39,72 M 2,78 M -13,21 M -18,06 M
EPS (Diluted) -22,61 0,11 -1,07 -2,41
Gross Profit — — — —
Operating Income -40,17 M -16,83 M -14,26 M -23,38 M
EBITDA — — — —
R&D Expenses 33,38 M 10,64 M 7,88 M 16,09 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — 282 064,0 282 064,0
Income Tax — 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 9,18 M 18,91 M 13,62 M 6,92 M
Total Liabilities 10,44 M 2,42 M 9,87 M 8,27 M
Shareholders' Equity -1,26 M 16,49 M 3,75 M -1,35 M
Total Debt — — 0,0 3,91 M
Cash & Equivalents 6,12 M 13,29 M 12,60 M 5,88 M
Current Assets 9,18 M 18,91 M 13,62 M 6,90 M
Current Liabilities 10,41 M 2,22 M 9,35 M 6,41 M